Babson Diagnostics

Babson Diagnostics

Reimagining blood testing for today's consumer.

Founded 2017

Austin, United States 65 employees Series B Total: $44.70M Health Care, Medical Devices

Babson Diagnostics is a health care startup founded in 2017 in the United States. The company's slogan, "Reimagining blood testing for today's consumer," encapsulates its mission to revolutionize the blood testing process. Babson Diagnostics is focused on bringing medically-accurate BetterWay™ Blood Testing to the pharmacy, aiming to empower individuals to take control of their health. This innovative approach involves rethinking every aspect of blood testing, including ordering, collection, handling, analysis, and result reporting, with the goal of making it less invasive and more convenient, accessible, and patient-centered. Notably, Babson Diagnostics secured a significant Series B investment of $31.00M on 29 June 2021. The investors involved in this landmark funding round include Emerald Development Managers, Infinitum Asset Management, Lago Consulting Group, Siemens Healthineers, and Prism Venture Management. Babson Diagnostics' emphasis on enhancing the blood testing experience for consumers, coupled with its recent substantial investment, positions the company as a promising player in the evolving health care industry. As the demand for more convenient and patient-centric health solutions continues to grow, Babson Diagnostics appears poised to make a meaningful impact.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$31.00M	5	Emerald Development Managers, Lago Consulting Group +3	29 Jun 2021
Series A	$13.70M	4	Genesis Merchant Capital, Lago Consulting Group +2	24 Sep 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$31.00M

Emerald Development Managers, Lago Consulting Group +3

29 Jun 2021

Series A

$13.70M

Genesis Merchant Capital, Lago Consulting Group +2

24 Sep 2020

FAQ About Babson Diagnostics

Reimagining blood testing for today's consumer.

Babson Diagnostics was founded in 2017.

Babson Diagnostics is headquartered in Austin, United States.

Babson Diagnostics operates in Health Care and Medical Devices. Its work centres on Blood Testing, Consumer Health, Medical Innovation and Pharmacy Services.

Babson Diagnostics has approximately 65 employees.

Babson Diagnostics has completed 2 funding rounds, raising a total of $44.70M. The latest funding stage is Series B.

Top alternatives and competitors to Babson Diagnostics include Entia, Truvian, Redmed Urgent Clinic, binx health, Orange Biomed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Babson Diagnostics and Entia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Babson Diagnostics

Funding Rounds & Investors (2)

Babson Diagnostics Alternatives & Competitors

FAQ About Babson Diagnostics